Precision BioSciences is a clinical-stage biotechnology and genome-editing enterprise headquartered in Durham, North Carolina. The company specializes in developing sophisticated in vivo and ex vivo gene-editing therapies utilizing its proprietary ARCUS genome-editing platform. Based on a naturally occurring homing endonuclease, the ARCUS technology enables highly specific DNA insertions, deletions, and repairs designed to treat complex genetic disorders, infectious diseases, and various types of cancers.